首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >P-STAT3 and IL-17 in tumor tissues enhances the prognostic value of CEA and CA125 in patients with lung adenocarcinoma
【24h】

P-STAT3 and IL-17 in tumor tissues enhances the prognostic value of CEA and CA125 in patients with lung adenocarcinoma

机译:肿瘤组织中的P-STAT3和IL-17增强了CEA和CA125在肺腺癌患者中的预后值

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: The present study aimed to examine the capability of p-signal transducer and activator of transcription (STAT)3 and interleukin-17 (IL-17), along with two known tumor markers carcinoembryonic antigen (CEA) and carbohydrate antigen 125 (CA125), for disease prognosis. Moreover, the associations among biomarkers and clinicopathological parameters were evaluated to uncover the potential mechanisms responsible for their correlations with lung adenocarcinoma (LAD) prognosis.
机译:目的:目前的研究旨在检测转录(统计)3和白细胞介素-17(IL-17)的P信号传感器和活化剂的能力,以及两种已知的肿瘤标志物癌丙烯抗原(CEA)和碳水化合物抗原125(CA125 ),用于疾病预后。 此外,评价生物标志物和临床病理学参数的关联,以发现揭示负责其与肺腺癌(LAD)预后相关的潜在机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号